A phase II trial of neoadjuvant gemcitabine, cisplatin plus tislelizumab followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Clinical efficacy, safety and the biomarker analysis

被引：0
|
作者：
Li, Xiao-Yun
Xie, Si-Yi
Chen, Qiu-Yan
Mai, Hai-Qiang
Tang, Lin-Quan
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-4025
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4025
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Induction chemotherapy followed by concurrent chemoradiation and nimotuzumab for locoregionally advanced nasopharyngeal carcinoma: preliminary results from a phase II clinical trial
    Huang, Jian-feng
    Zhang, Fu-zheng
    Zou, Qin-zhou
    Zhou, Le-yuan
    Yang, Bo
    Chu, Jian-jun
    Yu, Jia-hua
    Zhang, Hao-wen
    Yuan, Xiao-peng
    Tai, Guo-mei
    Liu, Fen-ju
    Ma, C-M Charlie
    ONCOTARGET, 2017, 8 (02) : 2457 - 2465
  • [42] Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
    Zhen Zeng
    Ruo-Nan Yan
    Li Tu
    Yu-Yi Wang
    Pei-Ran Chen
    Feng Luo
    Lei Liu
    Scientific Reports, 8
  • [43] Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
    Zeng, Zhen
    Yan, Ruo-Nan
    Tu, Li
    Wang, Yu-Yi
    Chen, Pei-Ran
    Luo, Feng
    Liu, Lei
    SCIENTIFIC REPORTS, 2018, 8
  • [44] Neoadjuvant Chemotherapy followed by Concurrent Chemoradiation for Locoregionally Advanced Stage Nasopharyngeal Carcinoma: Preliminary Report of Two Phase II Trials
    Kong, L.
    Lu, J. J.
    Hu, C.
    Guo, Y.
    Zhang, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S433 - S433
  • [45] Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial
    Chen, Lei
    Hu, Chao-Su
    Chen, Xiao-Zhong
    Hu, Guo-Qing
    Cheng, Zhi-Bin
    Sun, Yan
    Li, Wei-Xiong
    Chen, Yuan-Yuan
    Xie, Fang-Yun
    Liang, Shao-Bo
    Chen, Yong
    Xu, Ting-Ting
    Li, Bin
    Long, Guo-Xian
    Wang, Si-Yang
    Zheng, Bao-Min
    Guo, Ying
    Sun, Ying
    Mao, Yan-Ping
    Tang, Ling-Long
    Chen, Yu-Ming
    Liu, Meng-Zhong
    Ma, Jun
    LANCET ONCOLOGY, 2012, 13 (02): : 163 - 171
  • [46] Randomized Phase II Trial of Concurrent Cisplatin-Radiotherapy With or Without Neoadjuvant Docetaxel and Cisplatin in Advanced Nasopharyngeal Carcinoma
    Hui, Edwin P.
    Ma, Brigette B.
    Leung, Sing F.
    King, Ann D.
    Mo, Frankie
    Kam, Michael K.
    Yu, Brian K.
    Chiu, Samuel K.
    Kwan, Wing H.
    Ho, Rosalie
    Chan, Iris
    Ahuja, Anil T.
    Zee, Benny C.
    Chan, Anthony T.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (02) : 242 - 249
  • [47] A retrospective analysis of tislelizumab and GP regimen neoadjuvant therapy followed by concurrent chemoradiotherapy plus nimotuzumab in patients with high-risk nasopharyngeal carcinoma
    Zhang, Qinhua
    Lai, Mingfen
    Li, Fangming
    Chen, Jiarong
    Chang, Mingzhang
    Yang, Peixin
    Chen, Guojian
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [48] Nivolumab combined with chemoradiotherapy sparing concurrent cisplatin in high-risk locoregionally advanced nasopharyngeal carcinoma (PLATINUM): A multicenter, single-arm, phase II clinical trial
    Xu, Cheng
    Shen, Liangfang
    Yang, Kun-Yu
    Hu, Desheng
    Chen, Xiaozhong
    Lin, Shaojun
    Jin, Feng
    Zhou, Qin
    Peng, Gang
    Huang, Jing
    Wu, Yuan
    Tao, Changjuan
    Li, Ji-Bin
    Zhao, Hongyun
    Hong, Shu-Bin
    Huang, Hui-Ling
    Li, Wen-Fei
    Zhou, Guan-Qun
    Sun, Ying
    Ma, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (23_SUPPL) : 138 - 138
  • [49] Effect of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy on Nutritional Status in Locoregionally Advanced Nasopharyngeal Carcinoma Patients: A Prospective Observational Study
    Miao, J.
    Hu, C.
    Lin, S.
    Chen, X.
    Chen, Y.
    Zhong, Y.
    Jin, F.
    Lin, Q.
    Hu, X.
    Zhang, N.
    Wang, R.
    Wang, L.
    Wang, C.
    Zhu, M.
    Wu, H.
    Di, M.
    Huang, Y.
    Xie, C.
    Zhao, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E334 - E334
  • [50] Neoadjuvant camrelizumab plus chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A single-arm, phase II trial
    Gao, Jin
    Qian, Liting
    Zhou, Lingran
    Sun, Bin
    He, Jian
    Wang, Ru
    Zhang, Yangyang
    Yang, Liping
    Zhou, Yan
    Yang, Jing
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345